23 June 2015

McEwen Award for Innovation 2015 for Hans Clevers

Back to news

The McEwen Award for Innovation, supported by the McEwen Centre for Regenerative Medicine in Toronto, Ontario Canada, recognizes original thinking and ground-breaking research pertaining to stem cells or regenerative medicine that opens new avenues of exploration towards the understanding or treatment of human disease or affliction. The winner will receive $100,000 USD (to be split among winners if more than one person receives the award), a complimentary registration for the Annual Meeting, and recognition at the Annual Meeting during a plenary session.

Dr. Weissman and Dr. Clevers receive the award, in recognition of their long-standing contributions to the field and their identification, prospective purification and characterization of somatic tissue-associated stem cells and advancement of their research findings toward clinical applications. The winners will be honoured with the award at the Presidential Symposium of the ISSCR Annual Meeting, June 24, in Stockholm, Sweden.

During this annual meeting Hans Clevers will also be appointed as president-elect of the International Society for Stem Cell Research (ISSCR). The current ISSCR board of directors consists of 22 directors and includes the president, president-elect, vice president, past president, clerk and treasurer. Nominations for the board of directors were made by ISSCR members during fall 2014. http://www.isscr.org/home/about-us/isscr-leadership/2015-election-results

Prof. dr. Hans Clevers is senior groupleader at the Hubrecht Institute of Developmental Biology and Stem Cell Research In Utrecht, one of the research institutes of the Royal Netherlands Academy of Arts and Sciences (KNAW). He is Professor of Molecular Genetics at the UMC Utrecht and Utrecht University and Scientific Director of the Princes Maxima Centre for paediatric oncology. Clevers is a physician and medical researcher who was the first to identify stem cells in the intestine, is one of the world’s leading researchers on adult stem cells, the growth of organoids and their potential for regenerative therapy and personalized mediciner.